The University of Southampton
University of Southampton Institutional Repository

Adenosine A2A receptor mRNA expression in Parkinson's disease

Adenosine A2A receptor mRNA expression in Parkinson's disease
Adenosine A2A receptor mRNA expression in Parkinson's disease

The expression of the human adenosine A2A receptor was examined by reverse transcription polymerase chain reaction in post-mortem human brain tissue that was obtained from normal subjects and patients who died with Parkinson's disease. Adenosine A2A receptor mRNA was detected in both striatal (nucleus accumbens, caudate nucleus and putamen) and extrastriatal (globus pallidus and substantia nigra) brain regions. A significant decrease in the level of adenosine A2A receptor mRNA was found in the anterior and posterior caudate nucleus and anterior dorsal putamen, whereas a significant increase was observed in the substantia nigra pars reticulata of Parkinsonian brain when compared to age-matched controls. No change in adenosine A2A receptor mRNA levels was seen in any other brain region examined. This study demonstrates that A2A receptor mRNA expression is altered in the basal ganglia of patients who died with Parkinson's disease and who were receiving treatment with dopaminergic drugs. The adenosine A2A receptor appears subject to regulation by dopaminergic systems in human brain, though these data do not permit a distinction to be made between the effects of neuronal degeneration or drug treatment. The adenosine A2A receptor may therefore form a target for the treatment of basal ganglia disease.

Aged, Aged, 80 and over, Analysis of Variance, Caudate Nucleus, Electrophoresis, Polyacrylamide Gel, Female, Globus Pallidus, Humans, Male, Middle Aged, Nucleus Accumbens, Parkinson Disease, Putamen, RNA, Messenger, Receptor, Adenosine A2A, Receptors, Purinergic P1, Reverse Transcriptase Polymerase Chain Reaction, Substantia Nigra, Journal Article, Research Support, Non-U.S. Gov't
0304-3940
54-58
Hurley, Michael J.
07b0180f-8e32-4ce1-8185-e046a42ef15a
Mash, Deborah C.
8306c19c-264c-4b75-b534-39a039208779
Jenner, Peter
785c25df-ec64-4181-b057-26dd31cd9d84
Hurley, Michael J.
07b0180f-8e32-4ce1-8185-e046a42ef15a
Mash, Deborah C.
8306c19c-264c-4b75-b534-39a039208779
Jenner, Peter
785c25df-ec64-4181-b057-26dd31cd9d84

Hurley, Michael J., Mash, Deborah C. and Jenner, Peter (2000) Adenosine A2A receptor mRNA expression in Parkinson's disease. Neuroscience Letters, 291 (1), 54-58. (doi:10.1016/S0304-3940(00)01371-9).

Record type: Article

Abstract

The expression of the human adenosine A2A receptor was examined by reverse transcription polymerase chain reaction in post-mortem human brain tissue that was obtained from normal subjects and patients who died with Parkinson's disease. Adenosine A2A receptor mRNA was detected in both striatal (nucleus accumbens, caudate nucleus and putamen) and extrastriatal (globus pallidus and substantia nigra) brain regions. A significant decrease in the level of adenosine A2A receptor mRNA was found in the anterior and posterior caudate nucleus and anterior dorsal putamen, whereas a significant increase was observed in the substantia nigra pars reticulata of Parkinsonian brain when compared to age-matched controls. No change in adenosine A2A receptor mRNA levels was seen in any other brain region examined. This study demonstrates that A2A receptor mRNA expression is altered in the basal ganglia of patients who died with Parkinson's disease and who were receiving treatment with dopaminergic drugs. The adenosine A2A receptor appears subject to regulation by dopaminergic systems in human brain, though these data do not permit a distinction to be made between the effects of neuronal degeneration or drug treatment. The adenosine A2A receptor may therefore form a target for the treatment of basal ganglia disease.

This record has no associated files available for download.

More information

Published date: 8 September 2000
Keywords: Aged, Aged, 80 and over, Analysis of Variance, Caudate Nucleus, Electrophoresis, Polyacrylamide Gel, Female, Globus Pallidus, Humans, Male, Middle Aged, Nucleus Accumbens, Parkinson Disease, Putamen, RNA, Messenger, Receptor, Adenosine A2A, Receptors, Purinergic P1, Reverse Transcriptase Polymerase Chain Reaction, Substantia Nigra, Journal Article, Research Support, Non-U.S. Gov't

Identifiers

Local EPrints ID: 416142
URI: http://eprints.soton.ac.uk/id/eprint/416142
ISSN: 0304-3940
PURE UUID: 3cd04a71-51af-421d-9550-cf87a899dff0

Catalogue record

Date deposited: 06 Dec 2017 17:30
Last modified: 15 Mar 2024 17:13

Export record

Altmetrics

Contributors

Author: Michael J. Hurley
Author: Deborah C. Mash
Author: Peter Jenner

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×